Lisocabtagene maraleucel 1.1million-70million cells/ml / 1.1million-70million cells/ml dispersion for infusion vials
- SNOMED code
44881811000001105- Active compound
- Lisocabtagene maraleucel
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Prescribable
- ✅ Yes
- Dose form
- Not applicable
- Ingredients
- Lisocabtagene maraleucel
- Form & Route
- dispersioninfusion.intravenous
Dispersion for infusion, Intravenous - Controlled drug
- No Controlled Drug Status
Products
Breyanzi 1.1million-70million cells/ml / 1.1million-70million cells/ml dispersion for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd)
Breyanzi 1.1million-70million cells/ml / 1.1million-70million cells/ml dispersion for infusion vials
- SNOMED code
44851811000001100- Supplier
- Bristol-Myers Squibb Pharmaceuticals Ltd
- Licensed as
- Medicines - MHRA/EMA
- EMA (European Medicines Agency) Monitoring
- ▼ Yes, black triangle marked
- Availability restrictions
- Restricted Availability
- Licensed route
- Intravenous
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Breyanzi 1.1million-70million cells/ml / 1.1million-70million cells/ml dispersion for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) 1 pack44851911000001105 ref. pack | 💯 Available Legal category: POM | NHS Indicative Price £297,000 | • Hospital |
| — |
Reference packs
Lisocabtagene maraleucel 1.1million-70million cells/ml / 1.1million-70million cells/ml dispersion for infusion vials 1 pack
- SNOMED code
44851711000001108- Quantity and unit
- 1 pack
- Packs